Sanofi and Google announced that they plan to establish a new virtual Innovation Lab. The partners aim to radically transform how future medicines and health services are delivered by tapping into the power of emerging data technologies.
Sanofi and Google will leverage deep analytics across data sets to better understand key diseases and extract related patient insights.
(Source: Sanofi)
Paris/France — In view of the digital transformation, Sanofi expects the dawn of a new age biology and human health. This process offers the opportunity to enhance healthcare through partnerships with pioneering technology and analytics companies, says Ameet Nathwani, M.D., Chief Digital Officer, Chief Medical Officer & Executive Vice President, Medical at Sanofi. That is why his company wants to combine its biologic innovations and scientific data with Google’s capabilities, from cloud computing to state-of-the-art artificial intelligence.
The collaboration aims to change how the healthcare company develops new treatments and will focus on three key objectives: to better understand patients and diseases, to increase operational efficiency, and to improve the experience of patients and customers.
Event Tip The Smart Process Manufacturing Congress is the first German network platform to attend the process industry's digital transformation process in its full range of expertise. Experience on 24./25. September 2019 the future of the process industry: digital, modular, 4.0 and live.
The partners will leverage deep analytics across data sets to better understand key diseases and extract related patient insights. This is to enable Sanofi to research and develop more personalized approaches to treatment and identify accompanying technologies to improve health outcomes. The companies will apply technology and analytics on a large real world database to better understand what treatments work for patients. This aims to result in an improved ability to offer personalized treatment advice, thus optimizing patient care and reducing healthcare costs.
The companies also plan to apply artificial intelligence (AI) across diverse datasets to better forecast sales and inform marketing and supply chain efforts. Using AI will take into account real-time information as well as geographic, logistic and manufacturing constraints to help the accuracy of these complex activities.
Additionally, Sanofi IT will be modernizing its infrastructure by migrating some existing business applications to Google Cloud Platform (GCP). By leveraging automation, scalability, and agility —along with increases in data and analytic capabilities — the healthcare provider plans to accelerate and simplify legacy management, provide easy access to recent technologies and its integration into business plans. The transition to GCP will maximize operational cost efficiency and support business objectives, including the Innovation Lab.
(ID:45982272)
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.